SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Mimbari who wrote (12209)7/9/2013 7:24:17 PM
From: NTTG1 Recommendation

Recommended By
Pogeu Mahone

  Read Replies (1) | Respond to of 13111
 
You would imagine wrong, as usual. Many short term placebo controlled trials are conducted in cancer patients, particularly when studying non-progressing disease and short time frames are being used. Remember, PVCT is no longer in a position to study aggressive stage III or stage IV disease. Who knows, maybe red dye #2 is just as effective as PV-10?